Rizwana Ashraf

Dr. Rizwana Ashraf


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RDRohan D'Souza
Rohan D'Souza
RARizwana Ashraf
Rizwana Ashraf
SSShahab Sayfi
Shahab Sayfi
APAlexandra Prior
Alexandra Prior
APAllison Pihelgas
Allison Pihelgas
VJVenu Jain
Venu Jain
Background: There is conflicting evidence on whether falling insulin requirements (FIRs) in the third trimester are associated with adverse pregnancy outcomes. We synthesized published evidence to address this knowledge gap. Methods: We conducted a systematic review and meta-analysis, wherein we searched four bibliographic databases until September 04 2025 for articles describing third-trimester FIR and pregnancy outcomes. We assessed the risk of bias using the Quality In Prognosis Studies (QUIPS) tool, performed meta-analysis with pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) for maternal and perinatal outcomes and assessed certainty of evidence (CoE) using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Results: We identified 2044 articles, of which nine fulfilled the eligibility criteria. Third-trimester FIR has an important association with preeclampsia [OR 3.0 (95% CI 1.41–6.38, absolute event rate (AER) 15.9%, high CoE], probably has an important association with neonatal respiratory distress [OR 2.03 (95% CI 1.27–3.26), AER 15.8%, moderate CoE]; may have an important association with a composite of outcomes reflecting placental dysfunction [OR 2.32 (95% CI 1.07–5.03), AER 13.5%, low CoE] and preterm birth [OR 2.0 (95% CI 0.51–7.85), AER 9.3%, very low CoE]; and may not have an important association with stillbirth [OR 1.5 (95% CI 0.27–8.40), AER 0.05%, low CoE], small-for-gestational-age [OR 1.29 (95% CI 0.77–2.15), AER 1.8%, low CoE], or low Apgar score at 5 minutes [OR 1.68 (95% CI 0.68–4.14), AER 2.3%, low CoE]. Conclusions: The CoE regarding associations between third-trimester FIR and adverse pregnancy outcomes varies considerably, and it remains uncertain whether these associations reflect cause or effect. Therefore, a solitary finding of third-trimester FIR does not warrant early delivery and maternal–foetal surveillance should be based on the primary clinical diagnosis.

31 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MVMarina Vainder
Marina Vainder
NNNavneet Natt
Navneet Natt
PSParastoo Sayyar
Parastoo Sayyar
ASAmbreen Syeda
Ambreen Syeda
RARizwana Ashraf
Rizwana Ashraf
RDRohan D'Souza
Rohan D'Souza
Objective: To determine whether a third-trimester drop in insulin requirements in pregnant people with pre-existing diabetes is associated with a subsequent occurrence of adverse pregnancy outcomes. Research Design and Methods: We conducted a retrospective cohort study of patients with type 1 and 2 diabetes who were followed at a tertiary referral center in Toronto, Canada. We collected data on insulin dosing in the third trimester (after 28 weeks of pregnancy) and compared outcomes in those with and without a third-trimester drop of 15% or more in their total insulin requirements. Our primary outcome was a composite of stillbirth, spontaneous preterm birth or preterm premature rupture of membranes, and iatrogenic preterm birth or cesarean birth for fetal wellbeing concerns, occurring following the drop in insulin requirements. We conducted regression analyses controlling for early pregnancy glycosylated hemoglobin, body mass index, and diabetes-related microvascular disease, and presented results as odds ratios (OR) with 95% confidence intervals (95%CI). Results: We included 350 pregnant people—146 with type 1 and 204 with type 2 diabetes. Of these, 54 (15.4%) had a third-trimester drop of 15% or more in their total insulin requirements. There was no difference in the primary outcome between groups (OR 0.97; 95% CI 0.41–2.10). Conclusions: Based on this single-center study, limited by sample size and analytic constraints, in people with pre-existing diabetes, a third-trimester drop of ≥15% in total insulin requirements was not associated with subsequent occurrence of adverse pregnancy outcomes. Larger prospective studies looking at associations between a drop in insulin requirements and subsequent occurrence of adverse pregnancy outcomes are necessary to inform meta-analyses and clinical decision making.